400-21-0725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 5g | ￥ ĸŹŮŃŃ | > 10 | -- | 1 | 1 | 1 | 1 | ￥ ĸŹŮŃŃ | - + |
| 10g | ￥ ŞIJŮŃŃ | > 10 | -- | -- | 1 | 1 | -- | ￥ ŞIJŮŃŃ | - + |
| 25g | ￥ dždžĠŮŃŃ | > 10 | -- | 1 | 1 | -- | 1 | ￥ dždžĠŮŃŃ | - + |
| 100g | ￥ ŞƼŞŮŃŃ | -- | -- | -- | -- | -- | ￥ ŞƼŞŮŃŃ | - + | |
| 500g | ￥ ĸdžǡIJŮŃŃ | 1 | -- | -- | -- | -- | -- | ￥ ĸdžǡIJŮŃŃ | - + |
| 1000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
122.91
[1]. Anne Polk, et al. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 201 Dec;9():974-4.
[2]. Chika Fujii, et al. [Efficacy of AboundTM for hand-foot syndrome caused by capecitabine]. Gan To Kagaku Ryoho. 201 Nov;40(12):2457-9.
[]. Dan Rosmarin, et al. Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J Clin Oncol. 2014 Apr 1;2(10):101-9.
[4]. Hiroyuki Tanaka, et al. [Effect of capecitabine therapy on the blood levels of antiepileptic drugs - report of two cases]. Gan To Kagaku Ryoho. 2014 Apr;41(4):527-0.
[5]. Masatake Miyamoto, et al. [A case of primary duodenal cancer recurrence successfully treated with CapeOX therapy]. Gan To Kagaku Ryoho. 2014 Apr;41(4):495-.
H41-H50-H0-H402
P27-P20-P405-P501
GHS0
1222770 现货
￥ ƼŞŮŃŃ -1g
1215991 现货
￥ IJƆĠŮŃŃ -50mg
1259442 现货
￥ ŞŃƆŮŃŃ -10mg
11425 现货
￥ ƼƆŮŃŃ -1g
109 现货
￥ ǡIJŮŃŃ -5g
12457 现货
￥ ƼŞIJŮŃŃ -25mg
1905 货期咨询
207155 货期咨询
1714 货期咨询
沪ICP备1701945号
